Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Zonagen initiates pivotal trials of Vasomax

Aug. 16, 1996

Andropatch marketed in U.K.

Aug. 16, 1996

BASF to manufacture Ares-Serono's hGH

Aug. 16, 1996

Antidiabetic potential of CDP-571 assessed, rejected in human trials

Aug. 16, 1996

Antidiabetic efficacy of ABB demonstrated in rats

Aug. 16, 1996

TheraTech studies oral mucosal delivery system for GLP-1

Aug. 16, 1996

Beta3 agonists reported by Dainippon

Aug. 16, 1996

GW-5823: CCK-A agonist for treatment of obesity

Aug. 16, 1996

ImmuCell, Agri-Mark establish lactoferrin JV

Aug. 16, 1996

Hypolipidemic agents described by Bayer

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.